Learn About Sinus Cancer
MD Anderson
Ehab Hanna is an Otolaryngologist and a Surgical Oncologist in Houston, Texas. Dr. Hanna is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Olfactory Neuroblastoma, Adenoid Cystic Carcinoma, Sinus Cancer, Turbinectomy, and Endoscopy.
University Ear Nose And Throat Specialists
Carl H. Snyderman, MD, is a professor in the department of otolaryngology at the University of Pittsburgh School of Medicine and codirector of the UPMC Center for Skull Base Surgery. He specializes in otolaryngology-head and neck surgery, and cranial base surgery. Dr. Snyderman is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. His top areas of expertise are Cerebrospinal Fluid Leak, Olfactory Neuroblastoma, Sinus Cancer, Endoscopy, and Nerve Decompression.
MD Anderson
Shirley Su is an Otolaryngologist in Houston, Texas. Dr. Su is rated as an Elite provider by MediFind in the treatment of Sinus Cancer. Her top areas of expertise are Olfactory Neuroblastoma, Sinus Cancer, Nasopharyngeal Carcinoma, Turbinectomy, and Septoplasty.
Summary: This is a single arm phase II study that will evaluate the combination of pembrolizumab, docetaxel, and cisplatin or carboplatin (PDC) as single treatment modality in patients with stage II-IVb (T2-4, any N, M0) squamous cell carcinoma of the nasal cavity/paranasal sinuses (PNS SCC).
Summary: This phase I/Ib trial tests the safety and best dose of ipatasertib in combination with the usual treatment approach using chemotherapy together with radiation therapy (chemo-radiation) in patients with head and neck cancer. Ipatasertib is in a class of medications called protein kinase B (AKT) inhibitors. It may stop the growth of tumor cells and may kill them. Cisplatin, which is a chemotherapy ...